Name | Description | Size | Catalog # | Supplier | |
---|---|---|---|---|---|
A-484954 | An eEF-2K inhibitor; reduces eEF-2K autophosphorylation in various cancer… | 25 mg | 28279-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-484954 | An eEF-2K inhibitor; reduces eEF-2K autophosphorylation in various cancer… | 5 mg | 28279-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-485 | A p300 / CBP inhibitor (IC50 = 60 nM); decreases H3K27Ac levels in PC3 cel… | 1 mg | 24119-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-485 | A p300 / CBP inhibitor (IC50 = 60 nM); decreases H3K27Ac levels in PC3 cel… | 10 mg | 24119-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-485 | A p300 / CBP inhibitor (IC50 = 60 nM); decreases H3K27Ac levels in PC3 cel… | 25 mg | 24119-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-485 | A p300 / CBP inhibitor (IC50 = 60 nM); decreases H3K27Ac levels in PC3 cel… | 5 mg | 24119-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-61603 | A selective α1A-adrenergic receptor agonist that is at least 35-fold… | 1 mg | 17358-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-61603 | A selective α1A-adrenergic receptor agonist that is at least 35-fold… | 10 mg | 17358-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-61603 | A selective α1A-adrenergic receptor agonist that is at least 35-fold… | 5 mg | 17358-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-66 | A potent, selective inhibitor of the PI3K isoform p110α (IC50 = 32 n… | 1 mg | 17382-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-66 | A potent, selective inhibitor of the PI3K isoform p110α (IC50 = 32 n… | 10 mg | 17382-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-66 | A potent, selective inhibitor of the PI3K isoform p110α (IC50 = 32 n… | 25 mg | 17382-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-66 | A potent, selective inhibitor of the PI3K isoform p110α (IC50 = 32 n… | 5 mg | 17382-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-674563 | An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); al… | 1 mg | 18715-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-674563 | An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); al… | 10 mg | 18715-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-674563 | An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); al… | 5 mg | 18715-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-674563 | An orally available, reversible inhibitor of Akt (Ki = 11 nM for Akt1); al… | 500 µg | 18715-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
A6770 | An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… | 1 mg | 29972-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A6770 | An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… | 10 mg | 29972-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A6770 | An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… | 5 mg | 29972-5 |
CAYMAN CHEMICAL COMPANY |
More Info |
A6770 | An inhibitor of S1P lyase; induces accumulation of [3H]dhS1P in IT-79MTNC3… | 500 µg | 29972-500 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-740003 | A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… | 1 mg | 21256-1 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-740003 | A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… | 10 mg | 21256-10 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-740003 | A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… | 25 mg | 21256-25 |
CAYMAN CHEMICAL COMPANY |
More Info |
A-740003 | A selective P2X7 antagonist (IC50s = 40 and 18 nM for human and rat recept… | 5 mg | 21256-5 |
CAYMAN CHEMICAL COMPANY |
More Info |